Kala Bio (KALA): CFO sold, ~$11K

~$11K
Approx. value · 2,850 sh @ $3.74: 66K
Holds after · shares reported

Traded: Jun 3, 2025
Filed: Jun 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Jun 3, 2025 · this disclosureInsiderCFO sold ~$11K of KALA shares in the open market

What came next

Jun 3, 2025Insider · 4 peopleInsiders: 4 sales (~$70K)
Jun 24, 2025Insider · 5 peopleInsiders: 5 sales (~$123K)
Sep 28, 2025Company filing · Form 8-K · Restructuring, Other newsAnnounced job cuts, closures or a restructuring, and reported other company news“On September 28, 2025, the board of directors (the “Board”) of KALA BIO, Inc. (the “Company”) determined to cease development of KPI-012 and its mesenchymal stem cell secretome platform and to take steps to preserve cash as the Company explores its strategic options.”
Sep 29, 2025Company filing · Form 8-K · Debt acceleratedHad a debt or obligation accelerated“On September 29, 2025, KALA BIO, Inc. (the “Company”) received a written notice (the “Notice”) of event of default from Oxford Finance LLC (“Oxford”) with respect to that certain Loan and Security Agreement, dated as of May 4, 2021 (as amended, the “Loan Agreement”), by and among the Company, Combangio, Inc. and Oxford, as lender and collateral agent.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Kala Bio

OQRO holds no insider, Congress, fund or contract record for Kala Bio dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KALA page.

Other recent filings by Mary Reumuth, CHIEF FINANCIAL OFFICER

The full history of Mary Reumuth, CHIEF FINANCIAL OFFICER is on the profile page.

Other disclosures at Kala Bio

Everything OQRO holds on this company is on its KALA page.

Kala Bio (KALA)CFO sold ~$11K